Orforglipron Surges Ahead: Eli Lilly’s Oral GLP-1 Pill Beats Oral Semaglutide in Landmark Diabetes Trial
Eli Lilly has unveiled striking results from a head-to-head clinical trial showing its experimental oral GLP-1 pill, Orforglipron, outperformed…
-
-
Oral Semaglutide Found Cost-Saving Over Dulaglutide for Type 2 Diabetes in Taiwan, Study Shows
A new economic analysis finds that oral semaglutide may save money and improve outcomes for patients with type 2…
-
GLP-1 Drugs Could Revolutionise Knee Osteoarthritis Treatment for Patients with Obesity, Study Finds
New research suggests that GLP-1 drugs may offer a cost-effective treatment for people with knee osteoarthritis and obesity. The…
-
Biocon Secures U.S. FDA Approval for Liraglutide, Strengthening Its Position in the Booming Weight Loss Market
Biocon Limited has received approval from the U.S. Food and Drug Administration for its weight management drug, Liraglutide, branded…
-
Novo Nordisk Slashes Wegovy and Ozempic Prices by Up to 50% in Major U.S. Market Shake-Up
Novo Nordisk will slash U.S. list prices for its blockbuster drugs Wegovy and Ozempic by up to 50%. The…
-
Novo Nordisk Bounces Back With Triple-Action Obesity Data After CagriSema Setback
Novo Nordisk has moved quickly to steady investor nerves after disappointing trial results for its obesity candidate CagriSema. The…
-
CagriSema Falls Short of Tirzepatide in Pivotal Obesity Trial Showdown, affecting Novo Stocks
Shares of Novo Nordisk fell sharply after the company reported disappointing results from a closely watched obesity drug trial….
-
Lilly Wins FDA Nod for Zepbound Multi-Dose Pen, Boosting Convenience in Booming Weight-Loss Market
Eli Lilly and Company has won approval from the U.S. Food and Drug Administration for a new multi-dose version…
-
Lilly Bets Big on Obesity Pill, Leaving Peptron Deal in Limbo
Eli Lilly and Company is accelerating its push into the fast-growing obesity drug market. However, its renewed focus on…
-
Slimming Shots, Big Questions: Will the Olympics Ban Weight-Loss Drugs?
Weight-loss drugs could soon face stricter scrutiny in Olympic sport. The growing popularity of medications like Ozempic and Wegovy…
